Pricing Log in Create free account

Medpace Holdings, Inc. (MEDP) vs QIAGEN N.V. (QGEN)

Medpace Holdings, Inc. and QIAGEN N.V. are both Diagnostics & Research companies. Medpace Holdings, Inc. is the larger, with a market value of $17.8B against $10.5B — 1.7× the size. QIAGEN N.V. trades at the lower P/E: 26.1× against 34.6×. Medpace Holdings, Inc. grew revenue faster over the last twelve months: 20.4% against 2.96%. QIAGEN N.V. has the higher net margin (19.5% vs 18.2%) and the higher return on invested capital (6.62% vs 0.00%). Across the 22 metrics below, QIAGEN N.V. leads on 12 and Medpace Holdings, Inc. on 10.

Valuation

Metric MEDP QGEN Diagnostics & Research median
P/E 34.57 26.07 34.52
P/S 6.25 5.00 4.24
P/B 30.31 3.13 3.42
Price to free cash flow 26.56 23.83 33.51
EV/EBITDA 27.01 17.43 23.44
EV/Sales 6.04 5.40 5.18
Earnings yield 2.89% 3.84% (1.50%)
Free cash flow yield 3.77% 4.20% 0.00%

Profitability

Metric MEDP QGEN Diagnostics & Research median
Gross margin 72.24% 62.20% 48.32%
Operating margin 21.39% 21.21% (5.68%)
Net margin 18.24% 19.49% (4.10%)
Free cash flow margin 23.52% 20.98% 0.00%
Return on equity 117.88% 11.93% 0.00%
Return on assets 25.54% 6.99% (6.05%)
Return on invested capital 0.00% 6.62% 0.00%

Growth

Metric MEDP QGEN Diagnostics & Research median
Revenue growth (TTM) 20.35% 2.96% 8.99%
EPS growth (last fiscal year) 20.98% 424.32% 20.36%
Revenue growth, 5-year CAGR 22.27% 2.25% 7.30%
Net income growth, 5-year CAGR 25.50% 3.42% 0.00%

Health

Metric MEDP QGEN Diagnostics & Research median
Debt to equity 0.00 0.49 0.01
Current ratio 0.83 2.85 2.27
Net debt to EBITDA (0.88) 0.84 0.68

Dividend

Metric MEDP QGEN Diagnostics & Research median
Dividend yield — 0.69% 0.67%
Payout ratio — 0.18 0.20

Size

Metric MEDP QGEN Diagnostics & Research median
Market cap 17.76b 10.50b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack